Abstract
Epidemiologists and geneticists have tended to explore their respective domains independently, and as a consequence, these fields have drifted apart. The aim of this article is to outline how clues from genetics and epidemiology can be combined in order to optimize schizophrenia research. In particular, we will explore how recent developments in statistical genetics might be used to leverage clues from epidemiology. The ultimate goal of this type of research is to help generate better treatments for schizophrenia via the identification of shared pathways1 and to find modifiable risk factors that could lead to the primary prevention of schizophrenia.2

This publication has 43 references indexed in Scilit: